Neuroprotective effect of rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y

Cellular and Molecular Neurobiology

Volumn 30, Issue 5, 2010, Pages 759-767

  Park, Se Eun ^a   Kim, Seung ^b   Sapkota, Kumar ^a   Kim, Sung Jun ^a  

^a Chosun University   (South Korea)

^b Kwangju University   (South Korea)

Author keywords

Apoptosis; Dopaminergic cell; Hydrogen peroxide; Parkinson disease; Rosmarinus officinalis

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CASPASE 3; CASPASE 9; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; METHANOL; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; ROSMARINUS OFFICINALIS EXTRACT; TYROSINE 3 MONOOXYGENASE;

APOPTOSIS; ARTICLE; CELL LINE; CELL NUCLEUS; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NEUROPROTECTION; NUCLEAR CONDENSATION; NUCLEAR SIZE; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; SH SY5Y CELL; SOLVENT EXTRACTION; UPREGULATION;

AROMATIC-L-AMINO-ACID DECARBOXYLASES; BCL-2-ASSOCIATED X PROTEIN; CATECHOLAMINES; CELL DEATH; CELL LINE; CYTOPROTECTION; DNA FRAGMENTATION; DOPAMINE; HUMANS; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL PROTEINS; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; ROSMARINUS; TYROSINE 3-MONOOXYGENASE;

ROSMARINUS OFFICINALIS;

EID: 77956268398     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-010-9502-3     Document Type: Article

References (26)

1. Aruoma OI, Bahorun T, Jen LS (2003) Neuroprotection by bioactive components in medicinal and food plant extracts. Mutat Res 544:203-215
2. Beal MF (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci 991:120-131
3. Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615-647
4. Calne DB, Langston JW (1983) Aetiology of Parkinson's disease. Lancet 2:23-31
5. Cheung S, Tai J (2007) Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep 17:1525-1531
6. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM (1996) Molecular ordering of the cell death pathway-Bcl-2 and Bcl-x (L) function upstream of ced-3-like apoptotic proteases. J Biol Chem 271:4573-4576
7. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822
8. Greenamyre JT, Sherer TB, Betarbet R, Panov AV (2001) Complex I and Parkinson's disease. IUBMB Life 52:135-141
9. Kim SJ, Kim JS, Cho HS, Lee HJ, Kim SY, Kim S, Lee SY, Chun HS (2006) Carnosol a component of rosemary (Rosmarinus officinalis L.) protects nigral dopaminergic neuronal cells. Neuroreport 17:1729-1733
10. Lee HJ, Cho HS, Park E, Kim S, Lee SY, Kim CS, Kim do K, Kim SJ, Chun HS (2008) Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis. Toxicology 250:109-115
11. Leung AY, Foster S (1996) Encyclopedia of common natural ingredients used in foods, drugs and cosmetics, 2nd edn. Wiley, New York, pp 446-448
12. Licker V, Kövari E, Hochstrasser DF, Burkhard PR (2009) Proteomics in human Parkinson's disease research. J Proteomics 73:10-29
13. Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK (2002) Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 23:983-991
14. Mattson MP, Duan W, Chan SL, Cheng A, Haughey N, Gary DS, Gau Z, Lee J, Furukawa K (2002) Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol Aging 23:695-705
15. McCarthy TL, Kerry JP, Kerry JF, Lynch PB, Buckley DJ (2001) Evaluation of the antioxidant potential of natural food/plant extracts as compared with synthetic antioxidants and vitamin E in raw and cooked pork patties. Meat Sci 57:45-52
16. McNaught KS, Olanow CW (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. Ann Neurol 53: S73-S84
17. Orth M, Schapira AH (2002) Mitochondrial involvement in Parkinson's disease. Neurochem Int 40:533-541
18. Park JA, Kim S, Lee SY, Kim CS, Kim do K, Kim SJ, Chun HS (2008) Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport 19:1301-1304
19. Posadas SJ, Caz V, Largo C, De la Gándara B, Matallanas B, Reglero G, De Miguel E (2009) Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats. Exp Gerontol 44:383-389
20. Prehn JH, Bindokas VP, Jordán J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Thompson CB, Krajewski S, Reed JC, Miller RJ (1996) Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49:319-328
21. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172-188
22. Schapira AH (1999) Science, medicine, and the future: Parkinson's disease. BMJ 318:311-314
23. Shibata N, Kobayashi M (2008) The role for oxidative stress in neurodegenerative diseases. Brain Nerve 60:157-170
24. Yuan H, Zheng JC, Liu P, Zhang SF, Xu JY, Bai LM (2007) Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes. Neurosci Bull 23:125-130
25. Zhang Y, Dawson VL, Dawson TM (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 7:240-250
26. Ziv I, Melamed E, Nardi N (1998) Role of apoptosis in the pathogenesis of Parkinson's disease: a novel therapeutic opportunity. Mov Disord 13:865-870